Is Tasmea (ASX:TEA) Undervalued Following Full Year Results And A Higher Dividend?
Tasmea stock reacts to full year results and higher dividend
Tasmea (ASX:TEA) reported full year 2026 results with sales of A$1,293.31 million and net income of A$71.27 million. The board also declared a fully franked final dividend of A$0.085 per share.
Tasmea’s A$9.88 share price comes after a 1 day share price return of 1.96% and a 30 day share price return of 11.01%. The year to date share price return of 135.8% and 1 year total shareholder return of 130.55% indicate strong momentum building around the stock following these results and the higher dividend announcement.
Compare Tasmea’s move with other companies showing strong price action and resilient fundamentals by scanning the hand picked 10 high quality undervalued stocks now.
Tasmea now combines rising earnings, a higher dividend and a share price that has moved sharply this year. The next step is to test whether that momentum still lines up with what the business looks worth today.
Most Popular Narrative: 2.3% Undervalued
The most followed Tasmea valuation narrative places fair value at A$10.12, slightly above the latest A$9.88 close. This frames today’s strong share price run against a modest estimated discount.
The build out of data centers in Australia is creating a growing pool of work in transmission, substations and connections. Tasmea already has one of the largest remote specialist electrical workforces, which can support revenue and EBITA if contract wins continue.
Want to see what sits behind that fair value for Tasmea? The narrative leans heavily on fast revenue expansion, changing margins and a future earnings multiple that assumes the business keeps compounding. Curious which specific growth path and profitability profile have been built into that calculation?
Result: Fair Value of A$10.12 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Tasmea’s story could shift if data center project awards slow or miners pull back on sustaining CapEx. This may soften that recurring maintenance pipeline.
Find out about the key risks to this Tasmea narrative.
Another view of Tasmea using market multiples
The SWS DCF model points to a fair value of A$18.29 for Tasmea, which screens as undervalued against the A$9.88 share price. On a simpler P/E comparison, though, the picture is very different. Tasmea trades on 36.7x earnings versus a 31.3x fair ratio, 28.4x peers and 13.6x the wider construction group. That gap implies investors are already paying up for growth and quality. The open question is whether you see enough proof in future results to justify that premium.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With sentiment this mixed around Tasmea, it makes sense to move quickly and review the underlying data yourself before settling on a stance. To weigh both the upside potential and the concerns in one place, start with these 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Tasmea?
If Tasmea has your attention, do not stop there. Broaden your watchlist now so you are not relying on a single story to shape your returns.
- Target potential mispricings by scanning a 10 high quality undervalued stocks with solid fundamentals and room for the market to reassess them.
- Strengthen your income focus by reviewing a 8 dividend fortresses that balances yield with financial resilience.
- Lower portfolio stress by hunting through a 14 resilient stocks with low risk scores that prioritises steadier balance sheets and more predictable profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com